292 related articles for article (PubMed ID: 36305215)
1. Multidisciplinary chronic pain management strategies in patients with Ehlers-Danlos syndromes.
Gullapalli PA; Javed S
Pain Manag; 2023 Jan; 13(1):5-14. PubMed ID: 36305215
[TBL] [Abstract][Full Text] [Related]
2. Hypermobility, the Ehlers-Danlos syndromes and chronic pain.
Syx D; De Wandele I; Rombaut L; Malfait F
Clin Exp Rheumatol; 2017; 35 Suppl 107(5):116-122. PubMed ID: 28967365
[TBL] [Abstract][Full Text] [Related]
3. Pain in hypermobile Ehlers-Danlos syndrome: New insights using new criteria.
Bénistan K; Martinez V
Am J Med Genet A; 2019 Jul; 179(7):1226-1234. PubMed ID: 31075184
[TBL] [Abstract][Full Text] [Related]
4. A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice.
Feldman ECH; Homan KJ; Williams SE; Ting TV; Goldschneider KR; Kashikar-Zuck S
Pediatr Rheumatol Online J; 2023 Oct; 21(1):121. PubMed ID: 37845704
[TBL] [Abstract][Full Text] [Related]
5. Skin biopsy reveals generalized small fibre neuropathy in hypermobile Ehlers-Danlos syndromes.
Igharo D; Thiel JC; Rolke R; Akkaya M; Weis J; Katona I; Schulz JB; Maier A
Eur J Neurol; 2023 Mar; 30(3):719-728. PubMed ID: 36437696
[TBL] [Abstract][Full Text] [Related]
6. Functional neurological signs in hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders with suspected neuropathic pain.
Fernandez A; Jaquet M; Aubry-Rozier B; Suter M; Aybek S; Berna C
Brain Behav; 2024 Feb; 14(2):e3441. PubMed ID: 38409931
[TBL] [Abstract][Full Text] [Related]
7. [The Ehlers Danlos syndrome : a rare disease although commonly suspected].
Docampo E; Lehane F; Ribbens C
Rev Med Liege; 2023 Nov; 78(11):626-633. PubMed ID: 37955292
[TBL] [Abstract][Full Text] [Related]
8. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
[TBL] [Abstract][Full Text] [Related]
9. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
Bennett SE; Walsh N; Moss T; Palmer S
Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
[TBL] [Abstract][Full Text] [Related]
10. Predictors of pain and mobility disability in the hypermobile Ehlers-Danlos syndrome.
Kalisch L; Hamonet C; Bourdon C; Montalescot L; de Cazotte C; Baeza-Velasco C
Disabil Rehabil; 2020 Dec; 42(25):3679-3686. PubMed ID: 31060411
[No Abstract] [Full Text] [Related]
11. The association of pain with gait spatiotemporal parameters in children with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.
Jeong HJ; Engel JM; Muriello M; Basel D; Slavens BA
Gait Posture; 2024 Mar; 109():271-276. PubMed ID: 38368648
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
Teran-Wodzinski P; Kumar A
Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
[TBL] [Abstract][Full Text] [Related]
13. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
Martin A
Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of an online-delivered mindfulness meditation in Ehlers-Danlos syndrome (hEDS): effect on quality-of-life and participant lived experience.
Lattimore P; Harrison F
Disabil Rehabil; 2023 Nov; 45(23):3833-3840. PubMed ID: 36326346
[TBL] [Abstract][Full Text] [Related]
15. Surgical Management of Shoulder and Knee Instability in Patients with Ehlers-Danlos Syndrome: Joint Hypermobility Syndrome.
Homere A; Bolia IK; Juhan T; Weber AE; Hatch GF
Clin Orthop Surg; 2020 Sep; 12(3):279-285. PubMed ID: 32904109
[TBL] [Abstract][Full Text] [Related]
16. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
[TBL] [Abstract][Full Text] [Related]
17. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
Thwaites PA; Gibson PR; Burgell RE
J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
[TBL] [Abstract][Full Text] [Related]
18. Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
Aubry-Rozier B; Schwitzguebel A; Valerio F; Tanniger J; Paquier C; Berna C; Hügle T; Benaim C
Rheumatol Int; 2021 Oct; 41(10):1785-1794. PubMed ID: 34398260
[TBL] [Abstract][Full Text] [Related]
19. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.
Estrella E; Frazier PA
Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
